Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration

ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephane Bourgeois, Daniel F. Carr, Crispin O. Musumba, Alexander Penrose, Celestine Esume, Andrew P. Morris, Andrea L. Jorgensen, J. Eunice Zhang, D. Mark Pritchard, Panos Deloukas, Munir Pirmohamed
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
R
Acceso en línea:https://doaj.org/article/e356fc46996447cfa33cfd26c73f0564
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e356fc46996447cfa33cfd26c73f0564
record_format dspace
spelling oai:doaj.org-article:e356fc46996447cfa33cfd26c73f05642021-12-04T04:34:42ZGenome-Wide association between EYA1 and Aspirin-induced peptic ulceration2352-396410.1016/j.ebiom.2021.103728https://doaj.org/article/e356fc46996447cfa33cfd26c73f05642021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352396421005223https://doaj.org/toc/2352-3964ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients (n=1478) were recruited from 15 UK hospitals. Cases (n=505) were defined as patients with endoscopically confirmed PUD within 2 weeks of using aspirin and non-aspirin Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). They were compared to two control groups: patients with endoscopically confirmed PUD without any history of NSAID use within 3 months of diagnosis (n=495), and patients with no PUD on endoscopy (n=478). A genome-wide association study (GWAS) of aspirin-induced cases (n=247) was compared to 476 controls. The results were validated by replication in another 84 cases and 162 controls. Findings: The GWAS identified one variant, rs12678747 (p=1·65×10−7) located in the last intron of EYA1 on chromosome 8. The association was replicated in another sample of 84 PUD patients receiving aspirin (p=0·002). Meta-analysis of discovery and replication cohort data for rs12678747, yielded a genome-wide significant association (p=3·12×10−11; OR=2·03; 95% CI 1·65-2·50). Expression of EYA1 was lower at the gastric ulcer edge when compared with the antrum. Interpretation: Genetic variation in an intron of the EYA1 gene increases the risk of endoscopically confirmed aspirin-induced PUD. Reduced EYA1 expression in the upper gastrointestinal epithelium may modulate risk, but the functional basis of this association will need mechanistic evaluation. Funding: Department of Health Chair in Pharmacogenetics, MRC Centre for Drug Safety Science and the Barts Cardiovascular NIHR Biomedical Research Centre, British Heart Foundation (BHF)Stephane BourgeoisDaniel F. CarrCrispin O. MusumbaAlexander PenroseCelestine EsumeAndrew P. MorrisAndrea L. JorgensenJ. Eunice ZhangD. Mark PritchardPanos DeloukasMunir PirmohamedElsevierarticleNSAIDulcerAspirinGWASMedicineRMedicine (General)R5-920ENEBioMedicine, Vol 74, Iss , Pp 103728- (2021)
institution DOAJ
collection DOAJ
language EN
topic NSAID
ulcer
Aspirin
GWAS
Medicine
R
Medicine (General)
R5-920
spellingShingle NSAID
ulcer
Aspirin
GWAS
Medicine
R
Medicine (General)
R5-920
Stephane Bourgeois
Daniel F. Carr
Crispin O. Musumba
Alexander Penrose
Celestine Esume
Andrew P. Morris
Andrea L. Jorgensen
J. Eunice Zhang
D. Mark Pritchard
Panos Deloukas
Munir Pirmohamed
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
description ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients (n=1478) were recruited from 15 UK hospitals. Cases (n=505) were defined as patients with endoscopically confirmed PUD within 2 weeks of using aspirin and non-aspirin Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). They were compared to two control groups: patients with endoscopically confirmed PUD without any history of NSAID use within 3 months of diagnosis (n=495), and patients with no PUD on endoscopy (n=478). A genome-wide association study (GWAS) of aspirin-induced cases (n=247) was compared to 476 controls. The results were validated by replication in another 84 cases and 162 controls. Findings: The GWAS identified one variant, rs12678747 (p=1·65×10−7) located in the last intron of EYA1 on chromosome 8. The association was replicated in another sample of 84 PUD patients receiving aspirin (p=0·002). Meta-analysis of discovery and replication cohort data for rs12678747, yielded a genome-wide significant association (p=3·12×10−11; OR=2·03; 95% CI 1·65-2·50). Expression of EYA1 was lower at the gastric ulcer edge when compared with the antrum. Interpretation: Genetic variation in an intron of the EYA1 gene increases the risk of endoscopically confirmed aspirin-induced PUD. Reduced EYA1 expression in the upper gastrointestinal epithelium may modulate risk, but the functional basis of this association will need mechanistic evaluation. Funding: Department of Health Chair in Pharmacogenetics, MRC Centre for Drug Safety Science and the Barts Cardiovascular NIHR Biomedical Research Centre, British Heart Foundation (BHF)
format article
author Stephane Bourgeois
Daniel F. Carr
Crispin O. Musumba
Alexander Penrose
Celestine Esume
Andrew P. Morris
Andrea L. Jorgensen
J. Eunice Zhang
D. Mark Pritchard
Panos Deloukas
Munir Pirmohamed
author_facet Stephane Bourgeois
Daniel F. Carr
Crispin O. Musumba
Alexander Penrose
Celestine Esume
Andrew P. Morris
Andrea L. Jorgensen
J. Eunice Zhang
D. Mark Pritchard
Panos Deloukas
Munir Pirmohamed
author_sort Stephane Bourgeois
title Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
title_short Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
title_full Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
title_fullStr Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
title_full_unstemmed Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
title_sort genome-wide association between eya1 and aspirin-induced peptic ulceration
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e356fc46996447cfa33cfd26c73f0564
work_keys_str_mv AT stephanebourgeois genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT danielfcarr genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT crispinomusumba genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT alexanderpenrose genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT celestineesume genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT andrewpmorris genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT andrealjorgensen genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT jeunicezhang genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT dmarkpritchard genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT panosdeloukas genomewideassociationbetweeneya1andaspirininducedpepticulceration
AT munirpirmohamed genomewideassociationbetweeneya1andaspirininducedpepticulceration
_version_ 1718373001379971072